This is a phase I study to assess the safety and feasibility of IL-8 receptor modified patient-derived activated CD70 CAR T cell therapy in CD70+ adult glioblastoma.
- Investigator
- Ashley Ghiaseddin
- Status
- Accepting Candidates
- Ages
- 18 Years - 80 Years
- Sexes
- All